http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104906577-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 |
| filingDate | 2014-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104906577-B |
| titleOfInvention | A pharmaceutical composition for eradicating Helicobacter pylori and its preparation method |
| abstract | The invention relates to a pharmaceutical composition for eradicating Helicobacter pylori and a method for treating diseases and using the same. Wherein, the pharmaceutical composition contains three components of pronase, proton pump inhibitor (PPI) and antibiotics. The pharmaceutical composition can eradicate Helicobacter pylori through a specific use method and dose, prevent and treat various gastric diseases caused by Helicobacter pylori, gastric mucosa-associated lymphoid tissue (MALT) lymphoma, gastric cancer and the like. It overcomes the defects and shortcomings of incomplete treatment, low cure rate, and recurrent attacks in traditional treatment methods, greatly improves the clinical symptoms of patients, reduces the pain of patients, and improves the compliance of patients. |
| priorityDate | 2014-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 50.